메뉴 건너뛰기




Volumn 102, Issue 6-7, 2009, Pages 485-496

Clinical outcomes according to permanent discontinuation of clopidogrel or placebo in the CHARISMA trial

Author keywords

Acute coronary syndrome; Atherothrombosis; Clopidogrel; Rebound

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DRUG DERIVATIVE; TICLOPIDINE;

EID: 72949106125     PISSN: 18752136     EISSN: 18752128     Source Type: Journal    
DOI: 10.1016/j.acvd.2009.03.012     Document Type: Article
Times cited : (28)

References (29)
  • 1
    • 27644548513 scopus 로고    scopus 로고
    • Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: Randomised placebo-controlled trial
    • Chen ZM, Jiang LX, Chen YP, et al. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005;366:1607-21.
    • (2005) Lancet , vol.366 , pp. 1607-1621
    • Chen, Z.M.1    Jiang, L.X.2    Chen, Y.P.3
  • 2
    • 20244377701 scopus 로고    scopus 로고
    • Guidelines for percutaneous coronary interventions. The task force for percutaneous coronary interventions of the European society of cardiology
    • Silber S, Albertsson P, Aviles FF, et al. Guidelines for percutaneous coronary interventions. The task force for percutaneous coronary interventions of the European Society of Cardiology. Eur Heart J 2005;26:804-47.
    • (2005) Eur Heart J , vol.26 , pp. 804-847
    • Silber, S.1    Albertsson, P.2    Aviles, F.F.3
  • 4
    • 0035899289 scopus 로고    scopus 로고
    • Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation
    • DOI 10.1056/NEJMoa010746
    • Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502. (Pubitemid 32758501)
    • (2001) New England Journal of Medicine , vol.345 , Issue.7 , pp. 494-502
    • Yusuf, S.1    Zhao, F.2    Mehta, S.R.3    Chrolavicius, S.4    Tognoni, G.5    Fox, K.K.6
  • 5
    • 0037117649 scopus 로고    scopus 로고
    • Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: Simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide
    • DOI 10.1161/01.CIR.0000015464.18023.0A
    • Sabatine MS, Morrow DA, de Lemos JA, et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 2002;105:1760-3. (Pubitemid 34408881)
    • (2002) Circulation , vol.105 , Issue.15 , pp. 1760-1763
    • Sabatine, M.S.1    Morrow, D.A.2    De Lemos, J.A.3    Gibson, C.M.4    Murphy, S.A.5    Rifai, N.6    McCabe, C.7    Antman, E.M.8    Cannon, C.P.9    Braunwald, E.10
  • 8
    • 33846125284 scopus 로고    scopus 로고
    • Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation
    • [published online: Dec 5, 2006: doi:10.1001/jama.297.2.joc60179]
    • Eisenstein EL, Anstrom KJ, Kong DF, et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 2006 [published online: Dec 5, 2006: doi:10.1001/jama.297.2.joc60179].
    • (2006) JAMA
    • Eisenstein, E.L.1    Anstrom, K.J.2    Kong, D.F.3
  • 13
    • 33646233783 scopus 로고    scopus 로고
    • Drug eluting stents: An updated meta-analysis of randomised controlled trials
    • Roiron C, Sanchez P, Bouzamondo A, et al. Drug eluting stents: an updated meta-analysis of randomised controlled trials. Heart 2006;92:641-9.
    • (2006) Heart , vol.92 , pp. 641-649
    • Roiron, C.1    Sanchez, P.2    Bouzamondo, A.3
  • 16
    • 33645861080 scopus 로고    scopus 로고
    • Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events
    • Bhatt DL, Fox KA, Hacke W, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006;354:1706-17.
    • (2006) N Engl J Med , vol.354 , pp. 1706-1717
    • Bhatt, D.L.1    Fox, K.A.2    Hacke, W.3
  • 18
    • 28844455699 scopus 로고    scopus 로고
    • Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: Double-blind, randomised, controlled clinical trial
    • DOI 10.1016/S0140-6736(05)67760-4, PII S0140673605677604
    • Granger BB, Swedberg K, Ekman I, et al. Adherence to can-desartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial. Lancet 2005;366:2005-11. (Pubitemid 41773375)
    • (2005) Lancet , vol.366 , Issue.9502 , pp. 2005-2011
    • Granger, B.B.1    Swedberg, K.2    Ekman, I.3    Granger, C.B.4    Olofsson, B.5    McMurray, J.J.6    Yusuf, S.7    Michelson, E.L.8    Pfeffer, M.A.9
  • 22
    • 33845474736 scopus 로고    scopus 로고
    • Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12 rapid analyzer: The VERIfy Thrombosis risk ASsessment (VERITAS) study
    • DOI 10.1016/j.thromres.2006.01.019, PII S0049384806000491
    • Malinin A, Pokov A, Spergling M, et al. Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the verify thrombosis risk assessment (VERITAS) study. Thromb Res 2007;119:277-84. (Pubitemid 44918092)
    • (2007) Thrombosis Research , vol.119 , Issue.3 , pp. 277-284
    • Malinin, A.1    Pokov, A.2    Spergling, M.3    Defranco, A.4    Schwartz, K.5    Schwartz, D.6    Mahmud, E.7    Atar, D.8    Serebruany, V.9
  • 23
    • 33749520689 scopus 로고    scopus 로고
    • Premature withdrawal and alternative therapies to dual oral antiplatelet therapy
    • DOI 10.1093/eurheartj/sul055
    • Collet JP, Montalescot G. Premature withdrawal and alternative therapies to dual oral antiplatelet therapy. Eur Heart J 2006;8(Suppl. G):G46-52. (Pubitemid 44526986)
    • (2006) European Heart Journal, Supplement , vol.8 , Issue.SUPPL. G
    • Collet, J.-P.1    Montalescot, G.2
  • 28
    • 0030590746 scopus 로고    scopus 로고
    • A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
    • CAPRIE Steering Committee
    • CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329-39.
    • (1996) Lancet , vol.348 , pp. 1329-1339


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.